Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Eur Urol. 2019 Oct 20;77(3):333–341. doi: 10.1016/j.eururo.2019.09.036

Fig. 2 –

Fig. 2 –

Schematic of CDK12 mutations identified in the patient cohort. Mutations were primarily truncation mutations in the RS, PRM, or kinase domains, or alternatively missense mutations in the kinase domain. Additional details regarding the CDK12 mutations are outlined in Supplementary Table 1.

CDK12 = cyclin-dependent kinase 12; RS = arginine-serine domain; PRM = proline-rich motif.